Market movement
In 2024, hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis: derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in 2937 trade exhibited significant decline, with global flows reaching $438,447,153 and a three-year compound annual growth rate of -7.2% (five-year: -10.1%). The all-time peak of $1,752,760,760 was recorded in 2004; the current level is 75% below that high-water mark.
Over the 30-year observation window (1995–2024), 45% of years recorded positive growth, indicating significant cyclicality with frequent contractions. Trend momentum is decelerating (-4.4% acceleration).
